Alpha-amanitin inhibition of mouse brain form II ribonucleic acid polymerase and passive avoidance retention.
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D001487:Basidiomycota; D001921:Brain / Q000166:cytology / Q000201:enzymology*; D002467:Cell Nucleus / Q000201:enzymology; D002552:Cerebral Ventricles; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors*; D004305:Dose-Response Relationship, Drug; D006868:Hydrolysis; D066298:In Vitro Techniques; D007267:Injections; D007274:Injections, Intraperitoneal; D008099:Liver / Q000166:cytology / Q000201:enzymology; D008297:Male; D008568:Memory / Q000187:drug effects*; D051379:Mice; D008813:Mice, Inbred ICR; D009043:Motor Activity / Q000187:drug effects; D009183:Mycotoxins / Q000008:administration & dosage / Q000494:pharmacology*; D009842:Oligopeptides / Q000008:administration & dosage / Q000494:pharmacology*; D010456:Peptides, Cyclic / Q000008:administration & dosage / Q000494:pharmacology; D010477:Perfusion; D011132:Polyribosomes / Q000378:metabolism; D011402:Pronase; D012313:RNA / Q000302:isolation & purification; D012967:Sodium Dodecyl Sulfate; D013647:Task Performance and Analysis; D013997:Time Factors
D009183:Mycotoxins; D009842:Oligopeptides; D010456:Peptides, Cyclic; D012967:Sodium Dodecyl Sulfate; D012313:RNA; D012321:DNA-Directed RNA Polymerases; D011402:Pronase